All Relations between Moyamoya Disease and mmd

Publication Sentence Publish Date Extraction Date Species
Jeong Taek Yoon, Kyung Mi Lee, Jiwook Ryu, Ju In Par. Rapidly growing distal choroidal artery aneurysm re-rupture following revascularization for hemorrhagic Moyamoya disease: A case report. Clinical case reports. vol 12. issue 3. 2024-03-08. PMID:38455861. intracranial hemorrhage is the leading cause of neurological deficits and poor prognosis in adult patients with moyamoya disease (mmd). 2024-03-08 2024-03-10 Not clear
Kazufumi Kikuchi, Osamu Togao, Koji Yamashita, Takuro Isoda, Ataru Nishimura, Koichi Arimura, Akira Nakamizo, Koji Yoshimoto, Kousei Ishigam. Brain volume measured by synthetic magnetic resonance imaging in adult moyamoya disease correlates with cerebral blood flow and brain function. Scientific reports. vol 14. issue 1. 2024-03-05. PMID:38443400. moyamoya disease (mmd) is characterized by progressive arterial occlusion, causing chronic hemodynamic impairment, which can reduce brain volume. 2024-03-05 2024-03-08 Not clear
Jilan Liu, Chao Chen, Xianyun Qin, Jingtong Wang, Bin Zhang, Feng Ji. Plasma-derived exosomes contributes to endothelial-to-mesenchymal transition in Moyamoya disease. Heliyon. vol 10. issue 5. 2024-03-04. PMID:38434376. moyamoya disease (mmd) is a cerebrovascular disease with a high disability rate; however, its pathogenesis remains unknown. 2024-03-04 2024-03-06 Not clear
Jin Yu, Tongyu Chen, Xiang Li, Jincao Chen, Wei Wei, Jianjian Zhan. Liquid chromatography coupled to mass spectrometry metabolomic analysis of cerebrospinal fluid revealed the metabolic characteristics of moyamoya disease. Frontiers in neurology. vol 15. 2024-03-01. PMID:38426176. however, there has been limited research applying metabolomics to moyamoya disease (mmd). 2024-03-01 2024-03-03 Not clear
Samuel D Pettersson, Shunsuke Koga, Shan Ali, Alejandro Enriquez-Marulanda, Philipp Taussky, Christopher S Ogilv. Cerebral artery overexpression of the NMUR1 gene is associated with moyamoya disease: a weighted gene co-expression network analysis. Cerebrovascular diseases (Basel, Switzerland). 2024-02-25. PMID:38402855. this study aimed to elucidate mechanisms underlying moyamoya disease (mmd) pathogenesis and to identify potential novel biomarkers. 2024-02-25 2024-02-28 Not clear
Fangbin Hao, Gan Gao, Qingbao Guo, Simeng Liu, Minjie Wang, Zhengyao Chang, Hui Wang, Mingming Lu, Shitong Liu, Zhengxing Zou, Qian Zhang, Xiaopeng Wang, Heguan Fu, Jingjie Li, Cong Han, Lian Dua. Risk Factors for Massive Cerebral Infarction in Pediatric Patients With Moyamoya Disease. Pediatric neurology. vol 153. 2024-02-23. PMID:38394830. to explore the risk factors for preoperative massive cerebral infarction (mci) in pediatric patients with moyamoya disease (mmd). 2024-02-23 2024-02-26 Not clear
Daisuke Morit. Molecular structure and function of mysterin/RNF213. Journal of biochemistry. 2024-02-20. PMID:38378744. the author performed the first molecular cloning of the mysterin gene as the final step in genetic exploration of cerebrovascular moyamoya disease (mmd) and initiated the next round of exploration to understand its molecular and cellular functions. 2024-02-20 2024-02-23 Not clear
Chenglong Liu, Peicong Ge, Bojian Zhang, Liujia Chan, Yuheng Pang, Chuming Tao, Junsheng Li, Qiheng He, Wei Liu, Siqi Mou, Zhiyao Zheng, Zhikang Zhao, Wei Sun, Qian Zhang, Rong Wang, Yan Zhang, Wenjing Wang, Dong Zhang, Jizong Zha. Mass cytometry revealed the circulating immune cell landscape across different Suzuki stages of Moyamoya disease. Immunologic research. 2024-02-20. PMID:38376705. moyamoya disease (mmd) is a cerebrovascular disorder marked by progressive arterial narrowing, categorized into six stages known as suzuki stages based on angiographic features. 2024-02-20 2024-02-22 Not clear
Subash Phuyal, Shailesh B Gaikwad, Ajay Garg, Nishchint Jain, Manoj Nayak, Leve J Devaraja. Radiological Features and Management of Intracranial Aneurysms Associated With Moyamoya Disease: A Case Series of Single-Center Experience. Cureus. vol 16. issue 1. 2024-02-16. PMID:38361698. background moyamoya disease (mmd) can be a major cause of hemorrhagic stroke. 2024-02-16 2024-02-18 Not clear
Huang Yingqian, Dan, Lin Liping, Lai Zhiman, Xie Dingxiang, Li Zhuhao, Yang Zhiyun, Jiang Li, Zhao Jin. Longitudinal evaluation of cerebral perfusion evolution after revascularization surgery in moyamoya disease by CT perfusion. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. 2024-02-15. PMID:38360250. to assess the longitudinal evolution of cerebral perfusion after revascularization surgery in patients with moyamoya disease (mmd) by ct perfusion (ctp). 2024-02-15 2024-02-18 Not clear
Y Schwartzmann, S Spektor, S Moscovici, H Jubran, I Metanis, T Jouaba, J E Cohen, J M Gomori, R R Leke. Comparison between moyamoya disease and moyamoya syndrome in Israel. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. 2024-02-11. PMID:38342272. moyamoya patients can be divided into those with primary moyamoya disease (mmd) and those with moyamoya secondary to other known causes such as intracranial atherosclerosis (moymoya syndrome [mms]). 2024-02-11 2024-02-14 Not clear
Zihan Yin, Peicong Ge, Chaofan Zeng, Chenglong Liu, Yahui Zhao, Qihang Zhang, Hutao Xie, Anjie Wang, Xingju Liu, Shuai Kang, Qian Zhang, Yan Zhang, Dong Zhang, Jizong Zha. Association of lysine pathway metabolites with moyamoya disease. Clinical nutrition (Edinburgh, Scotland). vol 43. issue 3. 2024-02-10. PMID:38340411. the role of them in the identification of moyamoya disease (mmd) has not been elucidated. 2024-02-10 2024-02-14 Not clear
Taishi Honda, Masaki Ito, Haruto Uchino, Taku Sugiyama, Miki Fujimur. Moyamoya Syndrome Associated with Late-onset Idiopathic Aqueduct Stenosis Successfully Treated with Endoscopic Third Ventriculostomy. NMC case report journal. vol 11. 2024-02-08. PMID:38328525. moyamoya disease (mmd) is a rare idiopathic cerebrovascular disorder that causes transient ischemic attack (tia) and ischemic stroke in the pediatric population. 2024-02-08 2024-02-10 Not clear
Ryosuke Tashiro, Riki Anzawa, Tomoo Inoue, Ayame Mikagi, Dan Ozaki, Keita Tominaga, Takashi Inoue, Tomohisa Ishida, Miki Fujimura, Toyonobu Usuki, Hidenori Endo, Kuniyasu Niizuma, Teiji Tominag. The prognostic values of plasma desmosines, crosslinking molecules of elastic fibers, in the disease progression of Moyamoya disease. Bioorganic & medicinal chemistry. vol 100. 2024-02-07. PMID:38324946. moyamoya disease (mmd) is a cerebrovascular disease which is characterized by the chronic progression of steno-occlusive changes at the terminal portion of internal carotid arteries and the development of "moyamoya vessels." 2024-02-07 2024-02-10 Not clear
Peicong Ge, Zihan Yin, Chuming Tao, Chaofan Zeng, Xiaofan Yu, Shixiong Lei, Junsheng Li, Yuanren Zhai, Long Ma, Qiheng He, Chenglong Liu, Wei Liu, Bojian Zhang, Zhiyao Zheng, Siqi Mou, Zhikang Zhao, Shuang Wang, Wei Sun, Min Guo, Shuai Zheng, Jia Zhang, Xiaofeng Deng, Xingju Liu, Xun Ye, Qian Zhang, Rong Wang, Yan Zhang, Shaosen Zhang, Chengjun Wang, Ziwen Yang, Nijia Zhang, Mingxing Wu, Jian Sun, Yujia Zhou, Zhiyong Shi, Yonggang Ma, Jianpo Zhou, Shaochen Yu, Jiaxi Li, Junli Lu, Faliang Gao, Wenjing Wang, Yanming Chen, Xingen Zhu, Dong Zhang, Jizong Zha. Multiomics and blood-based biomarkers of moyamoya disease: protocol of Moyamoya Omics Atlas (MOYAOMICS). Chinese neurosurgical journal. vol 10. issue 1. 2024-02-07. PMID:38326922. moyamoya disease (mmd) is a rare and complex cerebrovascular disorder characterized by the progressive narrowing of the internal carotid arteries and the formation of compensatory collateral vessels. 2024-02-07 2024-02-10 Not clear
Dongxiao Xu, Jiaojiao Guo, Bingjie Zheng, Qiaowei Wu, Ilgiz Gareev, Ozal Beylerli, Aferin Beilerli, Huaizhang Sh. Risk Factors for Cerebral Hyperperfusion Syndrome After Combined Revascularization in Adult Patients with Moyamoya Disease. Current neurovascular research. 2024-02-07. PMID:38321905. cerebral hyperperfusion syndrome (chs) is known as a complication after bypass surgery for moyamoya disease (mmd). 2024-02-07 2024-02-09 Not clear
Sombat Muengtaweepongsa, Vatcharasorn Panpattanaku. Is medical management useful in Moyamoya disease? World journal of clinical cases. vol 12. issue 3. 2024-02-07. PMID:38322475. moyamoya disease (mmd), characterized by progressive internal carotid artery stenosis and collateral vessel formation, prompts cerebral perfusion complications and is stratified into idiopathic and moyamoya syndrome subtypes. 2024-02-07 2024-02-09 Not clear
Shihao He, Xilong Wang, Hongchuan Niu, Ziqi Liu, Junze Zhang, Xiaokuan Hao, Yanru Wang, Zhenyu Zhou, Yuanli Zhao, Rong Wan. Evaluation of cerebrovascular reactivity in moyamoya disease using oxygen-dependent magnetic resonance imaging. iScience. vol 27. issue 2. 2024-02-07. PMID:38323000. moyamoya disease (mmd) is a rare cerebrovascular disorder marked by progressive stenosis of the internal carotid arteries. 2024-02-07 2024-02-09 human
Tao Sun, Lixin Huang, Jun Sun, Zhimin Wu, Chuan Chen, Hui Wan. Persistent trigeminal artery in a patient with moyamoya disease:a case report and literature review. BMC neurology. vol 24. issue 1. 2024-02-02. PMID:38308221. in rare conditions, the pta could be combined with others cerebrovascular anomalies, moyamoya disease (mmd) is one of them. 2024-02-02 2024-02-05 Not clear
Yuan Yuan, Xuchao He, Yin Li, Lingji Jin, Yuhan Zhu, Gaojun Lin, Libin Hu, Hang Zhou, Yang Cao, Junwen Hu, Gao Chen, Lin Wan. The effects of anastomoses between anterior and posterior circulation on postoperative prognosis of patients with moyamoya disease. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2024-01-29. PMID:38285326. moyamoya disease (mmd) is a chronic ischemic cerebrovascular disease. 2024-01-29 2024-01-31 Not clear